Patents Assigned to AFFIRIS AG
  • MEANS FOR TREATING SYNUCLEINOPATHIES
    Publication number: 20120156234
    Abstract: The present invention relates to peptides or polypeptides for producing medicaments for preventing and/or treating synucleinopathies.
    Type: Application
    Filed: August 20, 2010
    Publication date: June 21, 2012
    Applicant: AFFIRIS AG
    Inventors: Markus Mandler, Harald Weninger, Radmila Santic, Christian Lahsnig
  • TREATMENT OF ATHEROSCLEROSIS
    Publication number: 20110275556
    Abstract: The present invention relates to the use of compounds for producing a medicament for preventing and/or treating atherosclerosis, atherosclerosis risk diseases and atherosclerosis sequelae.
    Type: Application
    Filed: August 8, 2008
    Publication date: November 10, 2011
    Applicant: AFFIRIS AG
    Inventors: Sylvia Brunner, Petra Luehrs, Frank Mattner, Walter Schmidt, Barbara Wittmann
  • COMPOUNDS FOR TREATING AMYLOIDOSES
    Publication number: 20110171243
    Abstract: The present invention relates to the use of mimotopes in the treatment of ?-Amyloidoses including but not limited to Alzheimer's disease, whereby said mimotopes are able to induce the in vivo formation of antibodies directed to non truncated A?1-40/42, and N-terminally truncated forms A?pE3-40/42, A?3-40/42, A?11-40/42, A?pE11-40/42 and A?14-40/42 without interfering with physiological functions of APP signalling.
    Type: Application
    Filed: June 12, 2009
    Publication date: July 14, 2011
    Applicant: AFFIRIS AG
    Inventors: Markus Mandler, Radmila Santic, Harald Weninger, Edith Kopinits
  • COMPOUNDS FOR TREATING BETA-AMYLOIDOSES
    Publication number: 20110097351
    Abstract: The present invention relates to the use of mimotopes in the treatment of diseases associated with ?-amyloid formation and/or aggregation (?-Amyloidoses) including Alzheimer's disease, whereby said mimotopes are able to induce the in vivo formation of antibodies directed to A?1-40/42, A?pE3-40/42, A?3-40/42 and A?11-40/42.
    Type: Application
    Filed: June 12, 2009
    Publication date: April 28, 2011
    Applicant: AFFIRIS AG
    Inventors: Markus Mandler, Christian Gieffers, Frank Mattner, Andrea Dolischka, Oleksandr Otava
  • MIMOTOPES OF ALPHA-SYNUCLEIN AND VACCINES THEREOF FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
    Publication number: 20110092434
    Abstract: The present invention relates to the use of at least one compound comprising the amino acid sequence: (X1)nX2X3PVX4X5X6(X7)m (Formula I), wherein X1 is any amino acid residue, X2 is an amino acid residue selected from the group consisting of aspartic acid (D) and glutamic acid (E).
    Type: Application
    Filed: February 23, 2009
    Publication date: April 21, 2011
    Applicant: AFFIRIS AG
    Inventors: Markus Mandler, Harald Weninger, Radmila Santic, Edith Kopinits
  • COMPOUNDS FOR TREATING SYMPTOMS ASSOCIATED WITH PARKINSON'S DISEASE
    Publication number: 20110092436
    Abstract: The present invention relates to a compound comprising a peptide for treating, preventing and/or ameliorating motor symptoms of Parkinson's disease, said peptide having a binding capacity to an antibody which is specific for an epitope of the amyloid-beta-peptide (A?).
    Type: Application
    Filed: June 12, 2009
    Publication date: April 21, 2011
    Applicant: AFFIRIS AG
    Inventors: Markus Mandler, Frank Mattner, Walter Schmidt